10-90918954-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014391.3(ANKRD1):āc.364C>Gā(p.Pro122Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,601,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_014391.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD1 | NM_014391.3 | c.364C>G | p.Pro122Ala | missense_variant | 4/9 | ENST00000371697.4 | NP_055206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD1 | ENST00000371697.4 | c.364C>G | p.Pro122Ala | missense_variant | 4/9 | 1 | NM_014391.3 | ENSP00000360762.3 |
Frequencies
GnomAD3 genomes AF: 0.0000345 AC: 5AN: 144802Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 247322Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133948
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1456288Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 12AN XY: 724698
GnomAD4 genome AF: 0.0000345 AC: 5AN: 144802Hom.: 0 Cov.: 30 AF XY: 0.0000284 AC XY: 2AN XY: 70370
ClinVar
Submissions by phenotype
ANKRD1-related dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 122 of the ANKRD1 protein (p.Pro122Ala). This variant is present in population databases (rs756392442, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ANKRD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 581670). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ANKRD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2024 | The p.P122A variant (also known as c.364C>G), located in coding exon 4 of the ANKRD1 gene, results from a C to G substitution at nucleotide position 364. The proline at codon 122 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at